Prednisone for the prevention of tuberculosis-associated IRIS (randomized controlled trial): Impact on the health-related quality of life.

MLA

Wouters, Edwin, et al. “Prednisone for the Prevention of Tuberculosis-Associated IRIS (Randomized Controlled Trial): Impact on the Health-Related Quality of Life.” Frontiers in Psychology, vol. 13, Oct. 2022, pp. 01-13. EBSCOhost, https://doi.org/10.3389/fpsyg.2022.983028.

APA

Wouters, E., Stek, C., Swartz, A., Buyze, J., Schutz, C., Thienemann, F., Wilkinson, R. J., Meintjes, G., Lynen, L., & Nöstlinger, C. (2022). Prednisone for the prevention of tuberculosis-associated IRIS (randomized controlled trial): Impact on the health-related quality of life. Frontiers in Psychology, 13, 01-13. https://doi.org/10.3389/fpsyg.2022.983028

Chicago

Wouters, Edwin, Cari Stek, Alison Swartz, Jozefien Buyze, Charlotte Schutz, Friedrich Thienemann, Robert J. Wilkinson, Graeme Meintjes, Lutgarde Lynen, and Christiana Nöstlinger. 2022. “Prednisone for the Prevention of Tuberculosis-Associated IRIS (Randomized Controlled Trial): Impact on the Health-Related Quality of Life.” Frontiers in Psychology 13 (October): 01-13. doi:10.3389/fpsyg.2022.983028.